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AbstrACt
Objectives This study aimed to estimate the incidence of 
DSM5 anorexia nervosa in young people in contact with 
child and adolescent mental health services in the UK and 
Ireland.
Design Observational, surveillance study, using the Child 
and Adolescent Psychiatry Surveillance System, involving 
monthly reporting by child and adolescent psychiatrists 
between 1st February 2015 and 30th September 2015.
setting The study was based in the UK and Ireland.
Participants Clinician-reported data on young people 
aged 8–17 in contact with child and adolescent mental 
health services for a first episode of anorexia nervosa.
Main outcome measures Annual incidence rates (IRs) 
estimated as confirmed new cases per 100 000 population 
at risk.
results 305 incident cases of anorexia nervosa were 
reported over the 8-month surveillance period and 
assessed as eligible for inclusion. The majority were 
young women (91%), from England (70%) and of white 
ethnicity (92%). Mean age was 14.6 years (±1.66) and 
mean percentage of median expected body mass index 
for age and sex was 83.23% (±10.99%). The overall IR, 
adjusted for missing data, was estimated to be 13.68 per 
100 000 population (95% CI 12.88 to 14.52), with rates of 
25.66 (95% CI 24.09 to 27.30) for young women and 2.28 
(95% CI 1.84 to 2.79) for young men. Incidence increased 
steadily with age, peaking at 15 (57.77, 95% CI 50.41 to 
65.90) for young women and 16 (5.14, 95% CI 3.20 to 
7.83) for young men. Comparison with earlier estimates 
suggests IRs for children aged 12 and under have 
increased over the last 10 years.
Conclusion These results provide new estimates of the 
incidence of anorexia nervosa in young people. Service 
providers and commissioners should consider evidence to 
suggest an increase in incidence in younger children.
trial registration number ISRCTN12676087.
IntrODuCtIOn
Anorexia nervosa is a serious and enduring 
eating disorder with high morbidity and the 
highest mortality among psychiatric disor-
ders.1 Young women are particularly suscep-
tible, with annual UK estimates of 37 new 
diagnoses of anorexia nervosa per 100 000 for 
girls aged 10–19 years, compared with 3 per 
100 000 for boys of the same age.2 Prevalence 
estimates in young people range from 0.3% 
to 0.6%.3 4
Accurate epidemiological estimates of the 
number of new anorexia nervosa cases per 
year and their sex and age profile are needed 
for causal investigations and service plan-
ning.2 However, available estimates in the 
UK are at least 10 years old.2 5–7 In addition, 
most estimates are derived from communi-
ty-based primary care records,2 5 which fail to 
accurately record all new cases.8 9 Undetected 
anorexia nervosa cases may present to acci-
dent and emergency and require immediate 
paediatric or psychiatric input, including 
inpatient admission. Some young people may 
therefore bypass primary care and, consis-
tent with UK guidelines,10 are likely to be 
assessed and diagnosed by a child and adoles-
cent psychiatrist in a secondary care setting, 
making secondary care records a more reli-
able source of data on anorexia nervosa inci-
dence than primary care registers.
Existing incidence data from secondary 
care settings in the UK are limited. One study, 
strengths and limitations of this study
 ► The study benefits from a large, nationally represen-
tative sample from across the UK and Ireland.
 ► This study used a National surveillance system to 
collect data and thus avoided biases inherent in 
studying clinical samples via a small number of cen-
tres in a limited number of geographical areas.
 ► Results were limited by missing data which were 
dealt with by adjusting observed incidence rates 
using assumptions about incidence among missing 
cases.
 ► Results are relevant to young people diagnosed with 
anorexia nervosa by child and adolescent psychia-
trists and not to those who are managed by general 
practitioners in primary care or those who have not 
come to the attention of services, for example, those 
who choose not to seek help.
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focusing only on adolescents aged 13 to 18, was limited 
to Greater London and reported presentation rates to 
child and adolescent mental health services (CAMHS), 
rather than incidence estimates.6 A second study, which 
used a national surveillance design, focused only on chil-
dren under 13.7 The current study aimed to estimate the 
incidence of anorexia nervosa in secondary care services 
for young people between the ages of 8 and 17 years in 
the UK and Ireland. This work formed part of a study 
exploring the cost-effectiveness of models of care for 
young people with eating disorders (the CostED study).11
MethODs
Design
An observational, surveillance study was undertaken using 
the Child and Adolescent Psychiatry Surveillance System 
(CAPSS). CAPSS is a system designed to ascertain cases 
of rare childhood mental health conditions in the UK 
and Ireland through monthly reporting by clinicians and 
relies on non-consent to maximise the accuracy of epide-
miological estimates. The CAPSS system has been oper-
ating since 200912 and is based on the well-established 
British Paediatric Surveillance Unit (BPSU) system.13
Inclusion and exclusion criteria
The study included young people between 8 and 17 
years of age, in contact with CAMHS for a first episode of 
anorexia nervosa according to DSM5 diagnostic criteria.14 
Anorexia nervosa is exceptionally rare in children under 
8 and the cut-off at 17 was due to the focus on young 
people in contact with CAMHS, with many young people 
transitioning to adult services at the age of 18. New cases 
were notified for a period of 8 months from 1st February 
to 30th September 2015. Cases whose clinician-reported 
data were insufficient to assess eligibility were excluded, 
as were duplicate cases notified more than once by the 
same or different clinicians.
Procedures
At the time of the study, CAPSS used a report card, known 
as the yellow card, containing a list of conditions being 
surveyed. Yellow cards, along with reporting instructions 
and protocols for new studies, are sent monthly from 
the CAPSS office to a mailing list of all hospital-, univer-
sity- and community-based child and adolescent consul-
tant psychiatrists across the UK and Ireland. Reporting 
clinicians are asked to check boxes against any of the 
reportable conditions they have seen in the preceding 
month, or to check a ‘nil return’ box and return the card 
to CAPSS. A tear-off slip is provided for respondents to 
keep a record of the patients reported. ‘Positive’ returns 
are allocated a unique CAPSS ID number and notified to 
the appropriate research investigator, who then contacts 
the reporting clinician directly to request completion of a 
questionnaire using the CAPSS ID to enable the clinician 
to identify the relevant patient.
For the CostED study, the yellow card contained a check 
box for anorexia nervosa and was sent to clinicians along 
with a protocol card detailing the case notification defini-
tion for anorexia nervosa. The case notification definition 
(see web extras) was based on DSM5 diagnostic criteria 
for anorexia nervosa and was intended to aid clinicians 
in their decision to tick ‘yes’ or ‘no’ on the yellow card. 
It was not intended to identify whether a case met study 
inclusion criteria, which was determined by the research 
group after receipt of all necessary data.
Data
Questionnaires were sent to clinicians who reported a 
positive case of anorexia nervosa, identified via the unique 
CAPSS ID number. Questionnaires were completed from 
clinical records and clinicians were asked to provide data 
relating to the time the case was initially assessed and 
diagnosed. The questionnaire covered clinical features 
to enable assessment of case eligibility, referral pathway 
information to ensure assessment and diagnosis had not 
happened prior to the study surveillance period, and 
a limited set of standard patient identifiers in line with 
CAPSS procedures and ethics requirements, which were 
used to describe the sample and to identify duplicate noti-
fications. In addition, clinicians were asked to confirm 
whether the case was a first episode of anorexia nervosa 
that had come to the attention of services.
The patient identifiers included NHS or Community 
Health Index (CHI) number (unique patient identifiers 
used in the regions of interest), hospital number, first half 
of postcode or town of residence for Ireland, sex, date of 
birth and ethnicity (white, mixed, Asian, black, Chinese, 
other or unknown). In Northern Ireland, identifiers were 
limited to age in years and months and hospital identifier 
rather than hospital number, to reduce the risk of patient 
identification given the small geographic area. All patient 
identifiable data from Northern Ireland were retained by 
the local research team, de-duplicated, anonymised and 
subsequently sent to the central research team in King’s 
College London for analysis as per requirements set out 
by the Northern Ireland Privacy Advisory Committee. All 
data storage were compliant with the EU General Data 
Protection Regulations.
Clinical features included: weight and height to calcu-
late body mass index (BMI) and percentage of median 
expected BMI for age and sex interpreted around the 
85% threshold15; the Health of the Nation Outcome 
Scales for Children and Adolescents (HoNOSCA),16 a 
routine outcome measure rating 13 clinical features on 
a five-point severity scale including behaviours, impair-
ments, symptoms, and social functioning of children and 
adolescents with mental health problems; the clinician 
completed Children's Global Assessment Scale (CGAS)17 
used to rate emotional and behavioural functioning of 
young people; and a range of symptoms relating to the 
diagnosis of anorexia nervosa.
Unreturned or incomplete questionnaires were chased 
via email and telephone. Cases where any symptom 
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required for case definition was absent, despite chasing, 
were assessed for eligibility by a consultant child and 
adolescent psychiatrist (MS).
Case eligibility
Cases were assessed as eligible for the study if: (1) they 
were between 8 and 17 years of age; (2) they had no 
previous episode of anorexia nervosa that had come 
to the attention of services; (3) they received a clinical 
assessment in the reporting service during the study 
surveillance period; (4) they had not been referred 
from another secondary health service (to ensure assess-
ment and diagnosis had not happened prior to the study 
surveillance period); and (5) the following clinical symp-
toms were present: ‘restriction of energy intake relative 
to requirements’ and ‘persistent behaviour that interferes 
with weight gain, despite low weight’. This broad defi-
nition was subsequently checked using a tighter DSM5 
analytic definition including the following symptoms:
1. Restriction of energy intake relative to requirements.
2. Intense fear of gaining weight or becoming fat or per-
sistent behaviour that interferes with weight gain, de-
spite low weight.
3. Perception that body shape/size is larger than it is or 
preoccupation with body weight and shape or lack of 
recognition of the seriousness of the current low body 
weight.
Only one case which met the broad criteria failed to 
meet the tighter criteria, thus confirming the validity of 
the broad criteria.
removal of duplicates
Duplicates were identified by comparing NHS/CHI 
numbers, hospital numbers/hospital identifiers and date 
of birth/age in years and months, as appropriate. The 
management of duplicates depended on the outcome for 
the original notification for which a duplicate was identi-
fied. Four scenarios were considered: (1) duplicates where 
the original notification met study inclusion criteria were 
excluded and the original retained; (2) duplicates where 
the original notification had been excluded because the 
young person was under 8 years of age or did not meet the 
clinical criteria were assessed as a new case to determine if 
the case now met eligibility criteria; (3) duplicates where 
the original notification was excluded due to a previous 
episode of anorexia nervosa, a diagnosis date prior to 
the study surveillance period or referral from another 
secondary care service, were excluded and (4) duplicates 
where the original notification contained insufficient 
information to judge eligibility were checked to see if the 
duplicate contained the missing information and, if avail-
able, the original notification was reassessed for eligibility 
and the duplicate managed as per the scenarios above.
Data analysis
Data analysis was performed using Stata IC V.14.2 and 
Microsoft Excel 2010. Observed incidence rates (IR0), 
defined as the number of new cases during a specified 
period of time in a population at risk for developing 
the disease, were calculated as follows: the number of 
confirmed new cases of anorexia nervosa in the 8-month 
surveillance period converted to 12 months [(N cases 
over 8 months/8) × 12], divided by the population at risk 
and multiplied by 100 000 to give the rate per 100 000 
young people.
 
IR0 = (confirmed new cases converted to 12 months)
/ the population at risk × 100 000  
The population at risk was calculated as the total 
number of children of each year of age and each sex 
in the UK and Ireland minus the number of prevalent 
cases who, once diagnosed, are no longer part of the ‘at 
risk’ population. Population data for 2015 were obtained 
from the Office for National Statistics for the UK18 and 
the Central Statistics Office for Ireland.19 To estimate the 
number of prevalent cases each year, incident cases in 
the previous age band were used as a proxy. For example, 
incident cases aged 8 were used as a proxy for prevalent 
cases in the estimation of the ‘at risk’ population aged 9 
and so on.
To consider incidence among unobserved missing 
cases, adjustments were needed for unreturned CAPSS 
notification cards and questionnaires. For CAPSS noti-
fication cards, just over half (50.16%) of all notification 
cards sent out were returned. To account for incidence 
among the 49.84% of unreturned cards, two assumptions 
were made, and an appropriate correction applied to IR0, 
the observed IR:
Assumption 1: To take into consideration the possibility 
that unreturned cards are more likely to be ‘nil’ returns, 
it was assumed that half (24.92%) of unreturned cards 
were ‘negative’ and half followed the same proportion 
of ‘negative’ and ‘positive’ as the returned cards. This 
assumption translates into a correction coefficient of 1.50 
derived from (24.92+50.16)/50.16.
Assumption 2: Making no assumptions of bias in the 
likelihood of unreturned cards being either positive 
or negative returns, it was assumed that all unreturned 
cards followed the same proportion of ‘negative’ and 
‘positive’ as returned cards. This assumption trans-
lates into a correction coefficient of 1.99 derived from 
(49.84+50.16)/50.16.
These assumptions provide a range of IRs, from a 
minimum (observed IR) to a maximum (assumption 2), 
within which the actual rate is likely to fall. We hypothe-
sised that assumption 1 provides the most realistic esti-
mate since it assumes a bias in the response rates with 
greater likelihood that unreturned cards are negative 
(‘nil’ returns) but does not assume all unreturned cards 
are ‘nil’ returns, which is the implicit assumption within 
IR0.
For unreturned questionnaires, approximately 
two-thirds (63%) of the questionnaires that were sent to 
clinicians reporting positive cases of anorexia nervosa 
were returned, leaving one-third (37%) unreturned. 
Since all these questionnaires relate to a ‘positive’ 
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Figure 1 Flow diagram of case ascertainment.
notification, we applied a correction coefficient of 1.59 
derived from (37+63)/63, which assumes that the IR for 
the unreturned questionnaires is the same as the IR iden-
tified in the returned questionnaires for each year of age.
We then combined the correction coefficients described 
above, to generate two adjusted IRs:
Adjusted incidence rate 1 (IR1) = Confirmed new cases 
of anorexia nervosa converted to 12 months, multiplied 
by the correction for unreturned CAPSS notification 
cards under assumption 1, multiplied by the correction 
for unreturned questionnaires, then divided by the popu-
lation at risk and multiplied by 100 000.
 
IR1 = (confirmed new cases converted to 12 months
× 1.50 × 1.59) / the population at risk × 100 000 
Adjusted Incidence rate 2 (IR2) = Confirmed new cases 
of anorexia nervosa converted to 12 months, multiplied 
by the correction for unreturned CAPSS notification 
cards under assumption 2, multiplied by the correction 
for unreturned questionnaires and then divided by the 
population at risk and multiplied by 100 000.
 
IR2 = (confirmed new cases converted to 12 months
×1.99× 1.59) / the population at risk × 100 000 
For each IR, IR0, IR1 and IR2, total, age-specific and 
sex-specific annual IRs for anorexia nervosa for the year 
2015 and 95% CIs were calculated based on the Poisson 
distribution20 using the Stata command ci means [N 
new anorexia nervosa cases 12 m], Poisson [exposure(-
total population)] for positive integers/whole incidence 
numbers (Stata interprets any non-integer decimal point 
number between 0 and 1 as the fraction of events and 
converts it to an integer number). Annual IRs were strati-
fied by discrete age and sex.
Public and patient involvement statement
The CostED study included a patient and a parent repre-
sentative on the study steering committee who contrib-
uted to the design, conduct and management of the 
study, including the incidence component.
results
Case ascertainment
Case ascertainment is outlined in figure 1. Over the 
8-month surveillance period, 6401 yellow cards were sent 
to reporting clinicians and 3211 (50%) were returned. 
Of these, 997 positive cases of anorexia nervosa were 
reported and 2214 were nil returns. Of the positive cases, 
48 (5%) were excluded due to clinicans stating that they 
did not wish to be included in the study (due to retire-
ment, shortage of reporting capacity and so on) or due 
to reporting errors. Questionnaires were sent to the 
remaining 949, and a further 352 (37%) positive cases 
were excluded as they failed to return the questionnaires, 
so no data were available to assess eligibility. Question-
naires were completed and returned for 597 notified 
cases, of which 292 (49%) were ineligible for reasons 
related to age, previous episode of anorexia nervosa, date 
of assessment outside the study’s surveillance period, 
referral from another secondary care service, insufficient 
information to assess diagnosis or duplicate notifications, 
leaving 305 incident cases of anorexia nervosa as the 
sample for analysis.
Demographics and clinical features
Of the 305 young people identified as having DSM5 
anorexia nervosa, the majority (91%) were girls of 
white ethnicity (92%) (see table 1). The mean age 
was 14.6 years (±1.66). Clinical variables suggest these 
young people were significantly impaired. Mean BMI 
was 16.50 kg/m2 (±2.25), where values of 16.00–16.99 
suggest moderate severity of anorexia nervosa. Mean 
percentage of median expected BMI for age and sex 
(the deviation from expected body weight) was 83.23% 
(±10.99%), falling within the range required for a diag-
nosis of anorexia nervosa (<85%). Mean CGAS score was 
44.61 (±14.08), which falls within the range for ‘obvious 
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Table 1 Characteristics of incident cases
N Mean (SD) or %
Age 305 14.56 (1.66)
Sex
  Female 279 91.48
  Male 26 8.52
Ethnicity
  Any white 274 91.64
  White and Asian 6 2.01
  White and black Caribbean 2 0.67
  White and black African 1 0.33
  Other mixed 1 0.33
  Indian 3 1.00
  Pakistani 2 0.67
  Bangladeshi 1 0.33
  Other Asian 4 1.34
  Black Caribbean 2 0.67
  Chinese 1 0.33
  Ethnicity not known 2 0.67
Clinical status
  BMI 304 16.50 (2.25)
  %e of Median expected BMI 303 83.23 (10.99)
  CGAS 280 44.61 (14.08)
  HoNOSCA 63 19.40 (8.17)
BMI, body mass index; CGAS, Children's Global Assessment 
Scale; HoNOSCA, Health of the Nation Outcome Scales for 
Children and Adolescents.
Table 2 Cases by region of the UK and Ireland
Region Incident cases (N) Incident cases (%)* Population (N) Population (%)
England 213 69.84 6 194 444 77.83
Scotland 44 14.43 561 490 7.06
Northern Ireland 41 13.44 231 822 2.91
Ireland 7 2.30 628 251 7.89
Wales 0 0.00 342 627 4.31
Total 305 7 958 634
*Does not sum to 100 due to rounding.
problems’ (41–50) on a scale from 1 to 100 (1 being the 
worst and 100 the best emotional and behavioural func-
tioning). Mean total HoNOSCA score was 19.40 (±8.17) 
on a scale from 0 to 52, indicative of a severity similar to 
that at inpatient admission.21 22
The proportion of the included sample notified from 
each region within the British Isles is reported in table 2, 
alongside the population of young people in each region 
by age. England has the largest population (78%) and 
notified 70% of new cases. Scotland, containing only 7% 
of the total population, notified 14% of the sample and 
Northern Ireland, containing only 3% of the population, 
notified 13% of the sample. By contrast, Ireland notified 
only 2% of cases, despite containing 8% of the popula-
tion, and Wales notified no eligible cases (some cases 
were notified but did not meet inclusion criteria), despite 
containing 4% of the population.
Incidence rates
Table 3 details IR0s and adjusted IRs (IR1 and IR2) by 
age. IRs for the total sample ranged from a minimum 
of 5.75 per 100 000 young people (95% CI 5.23 to 6.30; 
IR0) to a maximum of 18.22 per 100 000 young people 
(95% CI 17.29 to 19.18; IR2), with IR1, the rate hypoth-
esised to be the most accurate, falling between these two 
values at 13.68 per 100 000 population (95% CI 12.88 to 
14.52). Focusing on IR1 rates, total incidence increased 
steadily with age, peaking at 16 (30.37, 95% CI 26.70 to 
34.41), with a substantial drop at the age of 17 (14.35, 
95% CI 11.88 to 17.19).
Table 4 reports IRs by age and sex. Incidence among 
young men followed a similar pattern to overall IRs 
reported in table 3, being highest at the age of 16 (5.14) 
and half that at age 17 (2.54). The highest incidence 
among young women was seen a year earlier than for 
boys, at the age of 15 (57.77), with similar rates at age 16 
(56.95), dropping by more than half at age 17 (26.82).
DIsCussIOn
Principal findings
This study provides new estimates of incident cases of 
anorexia nervosa in young people aged 8–17 presenting 
to CAMHS services in the UK and Ireland. Our mid-range, 
missing data-adjusted estimate (IR1) of the incidence of 
anorexia nervosa in the full sample of young people aged 
8–17 years was approximately 14 per 100 000.
Comparison with other studies
This result is lower than previous primary care-based esti-
mates of 18–20 per 100 000 focusing on young people 
aged 10–19.2 5 This difference is due to the different age 
ranges in the studies; the inclusion of children as young 
as 8 in the current study, who have relatively low inci-
dence, and exclusion of adolescents aged 18–19, whose 
incidence is relatively high, makes the results difficult to 
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Table 3 Annual incidence of anorexia nervosa in young people aged 8–17 for 2015, reported per 100 000 young people
Age
Observed rate IR0 Adjusted rate IR1 Adjusted rate IR2
IR 95% CI IR 95% CI IR 95% CI
8 0.18 0.01 to 0.76 0.43 0.10 to 1.14 0.57 0.18 to 1.35
9 0.18 0.01 to 0.77 0.44 0.11 to 1.17 0.58 0.18 to 1.38
10 0.19 0.01 to 0.80 0.45 0.11 to 1.21 0.60 0.19 to 1.43
11 1.53 0.79 to 2.67 3.65 2.43 to 5.25 4.85 3.43 to 6.65
12 4.91 3.47 to 6.76 11.69 9.39 to 14.38 15.56 12.89 to 18.63
13 8.39 6.44 to 10.73 19.95 16.89 to 23.42 26.58 23.02 to 30.54
14 11.71 9.41 to 14.39 27.85 24.25 to 31.84 37.10 32.92 to 41.66
15 12.39 10.05 to 15.10 29.47 25.80 to 33.52 39.25 35.50 to 43.88
16 12.76 10.42 to 15.47 30.37 26.70 to 34.41 40.45 36.19 to 45.07
17 6.03 4.47 to 7.96 14.35 11.88 to 17.19 19.12 16.24 to 22.35
Total 5.75 5.23 to 6.30 13.68 12.88 to 14.52 18.22 17.29 to 19.18
IR, incidence rate.
compare. However, comparing rates for 10–14 year olds, 
available in the current study and in the most recent of 
these published estimates, produces similar incidence 
rates, with rates of 12.6 per 100 000 in the current study, 
compared with 13.1 per 100 000 in 2009.2 For females, the 
rates are 23.3 per 100 000 in the current study compared 
with 24.0 per 100 000 in 2009 and for males, 2.4 and 
2.5 per 100,000, respectively. However, this comparison 
should be treated with caution given the very different 
settings—primary care versus secondary care.
Existing secondary care estimates of the incidence of 
anorexia nervosa in the UK are limited to children under 
the age of 13, with an overall incidence of 1.09 per 100 000 
reported for children aged between 6 and 12 between 
2005 and 2006.7 The methodology for this study was very 
similar to the CostED methodology, using the CAPSS 
system but additionally the BPSU System. For comparison 
with the current study, the incidence rate for children 
between 8 and 12 was approximately 1.5 per 100 000 for 
DSMIV anorexia nervosa or 2.1 per 100 000 for DSMIV 
anorexia nervosa plus those classified as ‘other eating 
disorders’ meeting CostED criteria for DSM5 anorexia 
nervosa (estimated from the original data by DN). This 
compares to a rate of 3.2 per 100 000 in the current study 
for children of the same age. This estimate is higher than 
both of the 2006 estimates suggesting that incidence rates 
for younger children have increased over time.
The results presented are also supported by interna-
tional evidence. One study carried out in Italy demon-
strated a significant reduction in age at onset for anorexia 
nervosa in consecutive outpatient referrals between 1985 
and 2008 (n=1666).23 A second study exploring time 
trends in the incidence of anorexia nervosa, which was 
carried out using data from the Norwegian National 
Patient Register, found overall rates of anorexia nervosa 
to be stable between 2010 and 2016 for the sample as a 
whole, but increasing for young females aged between 10 
and 14.24
strengths and weaknesses of the study
The large, nationally representative sample of this 
study is a strength. The study included young people 
with anorexia nervosa, diagnosed using DSM5 criteria, 
from across the UK and Ireland and thus avoided biases 
inherent in studying clinical samples via a small number 
of centres in a limited number of geographical areas. The 
results are of relevance primarily to the UK and Ireland 
but may be of value to other high-income countries.
With only a 50% case notification response rate from 
CAPSS clinicians and a third of questionnaires not 
returned, missing data were a major constraint. There are 
many reasons why clinicians may fail to return notifica-
tion cards or questionnaires, including changes in place 
of employment, competing priorities, or the belief that 
cases will be reported by a colleague.13 This problem was 
addressed by adjusting the observed incidence rates using 
assumptions about incidence among both missing case 
notifications and missing questionnaires.
The methodology is also limited to young people seen 
by child and adolescent psychiatrists. Cases that would not 
be identified by this methodology include those who have 
not come to the attention of services, for example, those 
who choose not to seek help, those managed by general 
practitioners in primary care, and those in the care of 
mental health services without psychiatric input, such 
as nurse-led facilities. This latter concern was an issue in 
Northern Ireland where, due to initial low numbers of 
notifications, investigation by the research team identi-
fied a number of nurse-led facilities which were invited 
to contribute, and subsequently reported just over half of 
all cases in Northern Ireland. In terms of missing primary 
care cases, given UK guidelines for assessment and diag-
nosis of anorexia nervosa to be carried out by child and 
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Web extras
Case notification definition
Please report any child/young person aged 8–17 years and 11 months 
inclusive, who meets the case notification definition criteria below for 
the first time in the last month. One bullet point criterion from each 
group below should be fulfilled.
Group A
 ► Restriction of food, low body weight, or
 ► Weight less than expected for age.
Group B
 ► Fear of gaining weight, or
 ► Fear of becoming fat, or
 ► Behaviour that interferes with weight gain, for example, excessive 
exercising, self-induced vomiting, use of laxatives and diuretics.
Group C
 ► Body image disturbance, or
 ► Persistent lack of recognition of the seriousness of the current low 
body weight.
Exclusions
 ► Patients who are not underweight.
 ► Patients with bulimia nervosa, binge eating disorder, avoidant re-
strictive food intake disorder or other failure to thrive presentations.
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adolescent psychiatrists in secondary care settings,10 it is 
reasonable to assume that many of those cases remaining 
in primary care would not meet criteria for DSM5 
anorexia nervosa. It is also possible that current inpatient 
cases are under-represented; although notifications were 
sent to all child and adolescent psychiatrists, including 
those working in inpatient settings, the main focus of 
the CostED study was the evaluation of community-based 
services, and so clinicians may have mistakenly focused on 
notification of community-based cases.
It must also be borne in mind that service-level (rather 
than population-level) incidence rates are sensitive to 
external factors, including service availability, funding and 
commissioning decisions, parental and school awareness, 
and stigma, all of which will impact on observed trends in 
incidence rates over time. The nature of community-based 
eating disorders services for children and adolescents in 
England has started to change following the publication 
of commissioning standards in June 2015,25 as well as 
investment of £30 million to support the development of 
these services. The CostED incidence data were collected 
in 2015, 1 year before the first allocation of funding to 
services was made in 2016, and thus these initiatives, 
which may result in increases in observed incidence rates 
in the future, are not reflected in the data presented. 
Nevertheless, these estimates are approximately ten years 
more recent than existing secondary care data for the UK 
(collected between 2005 and 2006)7 and cover a wider 
age range.
unanswered questions and future research
Future research should explore the development of 
earlier interventions, given evidence of an increase in 
incidence in young children suggesting that onset of 
anorexia nervosa may be starting earlier for some young 
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people than suggested by previous research. Research is 
also needed to identify approaches to the assessment of 
incidence simultaneously in primary and secondary care. 
Multinational studies should be considered for better 
assessment and exploration of incidence rates in young 
men.
COnClusIOn
These results provide new estimates of the incidence of 
anorexia nervosa in young people in the UK and Ireland. 
While firm conclusions relating to changes in incidence 
rates over time for the entire sample cannot be drawn 
due to lack of existing secondary care evidence, service 
providers and commissioners should consider evidence 
to suggest an increase in incidence in younger children.
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